Contraceptives Market - Industry Analysis
The global contraceptives market generated a revenue of $28,175 million in 2015 and is estimated to reach $43,812 million by 2022, registering a CAGR of 6.4% during the analysis period. Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy.
The contraception encompasses the use of drugs (oral pills, injectable contraceptives, and topical contraceptives) and devices (condoms, intrauterine device [IUD], diaphragms, sponges, patches, implants, vaginal rings, and others). The growth in focus towards the need of family planning and preventing unintended pregnancy fuels the market growth. In addition, the increase in use of contraception in young women along with the rise in higher educational attainment propels the market growth. Moreover, health issues associated with teenage pregnancies, increase in awareness of modern contraception, and rise in use of oral pills as a key method to avoid unplanned pregnancy further drive the market growth. However, health risks associated with the use of contraceptives, availability of alternate contraceptive methods, and lack of social acceptance might adversely affect the market growth.
Contraceptives Market Segmentation:
The contraceptives industry is segmented on the basis of product, age group, education, end-user, and geography. Contraceptive drugs and devices are two major product categories of the contraceptives market. Contraceptive drugs are further categorized into oral (pills), injectable, and topical contraceptives. The oral contraceptives industry is the largest within the contraceptive drug market owing to the widespread use of oral pills by women. This is mainly because they are proven to be highly effective up to 99% in preventing pregnancy. In addition, contraceptive devices are further categorized into condoms, IUDs, diaphragms, sponges, patches, implants, and vaginal rings. In terms of revenue, the condoms are the most commonly used contraceptive devices accounting for around two-thirds of the contraceptives market share in 2015. However, IUDs gain momentum and are expected to grow at a faster pace during the analysis period.
Contraceptives Market Product Segmentation:
Contraceptives Market Analysis by End User:
Contraceptive drugs and devices are employed by a set of end users for pregnancy control, of sexually transmitted infections (STIs), and for birth control & family planning. In this report, the end user comprises of household, clinics, and hospitals.
Households accounted for the largest share in the contraceptive market owing to the widespread consumption of oral pills and condoms to prevent unintended pregnancy and STIs. Contraceptives preferred for use in households include oral pills, topical contraceptives, vagina ring, contraceptive patches, contraceptive diaphragms, and sponges. These contraceptives help to reduce the risk of pregnancy and STIs. The increase in use of contraceptives at home has improved health-related outcomes, such as maternal & infant mortality, reduced risk of STIs, such as HIV, hepatitis B, syphilis, and gonorrhea along with improved economic outcomes of a family.
Contraceptives offered in hospitals comprise of IUD, injectable contraceptives, sub-dermal contraceptive implants, contraceptive vaginal rings, and others, where IUDs become one of the most preferable choice. Hospitals provide permanent methods such as male and female sterilization. However, IUDs and implants are primarily offered at hospitals to stop birth control. These methods require special training, experienced experts, and service delivery conditions to safely carry out required procedures.
Clinics hold a significant share in the contraceptive industry as they provide services for all ages and genders that include low cost contraceptives, infection tests, pregnancy tests & diagnosis, non-judgmental birth control counseling, and sexual health information. The clinical methods of family planning were more often available in health centers and dispensaries. Also, clinics offer confidential and free advice along with information regarding better contraceptive method and sexual health. This has specifically contributed for the high growth for clinics in the contraceptive market.
Now-a-days, clinics provide FDA-approved contraceptive methods, which include oral contraceptives, long-acting reversible contraception (IUD or implant), injectable (Depo-Provera), other hormonal methods (patch or ring), male barrier (condom), female barrier (diaphragm or cervical cap or sponge or female condom or spermicides), and emergency contraception.
North America Contraceptive market analysis:
The North American region comprises three countries in the reportU.S., Canada, and Mexico. North America has experienced a minimal change in the contraceptive methods usage rates and the usage has been decreased by 0.3%; however, the region has the highest contraceptive prevalence74.8%. Effective contraceptive methods such as pills, male condom, IUD, injectable, implant, and other modern barrier methods dominate the North American region. According to Guttmacher Institute, the percentage of women in the country using long-acting reversible contraceptives (for instance, IUDs and hormonal implants) has increased from 9% in 2009 to about 12% in 2012.
The combined hormonal contraceptives segment dominates the overall drugs segment in North America, which lead to their high usage in the prevention of pregnancy or birth control. According to the Affordable Care Act, the health insurance companies provide 100% insurance to the users of the contraceptive methods.
The report provides a comprehensive analysis of the key players that operate in the contraceptives market, namely, The Female Health Company, Teva Pharmaceutical Industries Limited, Allergan plc, Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.
Other players in the value chain include Reckitt Benckiser Plc, Warner Chilcott Company, BioSante Pharmaceuticals Inc., Agile Therapeutics Inc., HLL Lifecare Limited, MANKIND Pharmaceuticals, TTK HealthCare, Boehringer Ingelheim GmbH, Watson Pharmaceuticals, Inc., V-Care Pharma Pvt. Ltd., Vardhman Life care pvt. Ltd., and Cipla Limited.
CONTRACEPTIVES MARKET KEY BENEFITS
- The study provides an in-depth analysis of the entire contraceptives market size with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis by product (both contraceptive drugs and devices) interprets the need to prevent unintended pregnancy and STIs.
- The report provides information regarding key drivers, restraints, and opportunities with a detailed impact analysis.
- Porter’s Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.
CONTRACEPTIVES MARKET KEY SEGMENTS
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Female Condoms
- Male Condoms
- Intrauterine Devices (IUDs)
- Hormonal IUDs
- Copper IUDs
- Vaginal Rings
- 15‐24 years
- 25‐34 years
- 35‐44 years
- Above 44 years
- Less than high school
- High school graduate
- College graduate
- Other college degrees
BY END USER
- North America
- Rest of Europe
- Rest of Asia-Pacific
- South Africa
- Rest of LAMEA